NCT01081704View on ClinicalTrials.gov

A Study of the Pharmacokinetics of Ustekinumab in Chinese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy
Interventions
DRUG

ustekinumab

Single dose of 45 mg subcutaneous injection

DRUG

ustekinumab

Single dose of 90 mg subcutaneous injection

Trial Locations (1)

Unknown

Beijing

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY